AAN 2026
4 stories
-
healthCAR-T Therapy Demonstrates Significant Progress in Stiff Person Syndrome Study
Pivotal Phase II KYSA-8 study presented at AAN 2026 shows CAR-T therapy miv-cel offers substantial clinical improvements for Stiff Person Syndrome patients.
-
healthUlixacaltamide Shows Sustained Essential Tremor Response in Phase III Trial
New data from a Phase III study presented at AAN 2026 indicates ulixacaltamide maintained response in essential tremor patients, highlighting its potential as a new treatment option.
-
healthRapid Genome Sequencing Accelerates Neurologic Diagnosis in Adults
New findings presented at AAN 2026 show rapid whole genome sequencing identified genetic causes in nearly a quarter of hospitalized adults with unexplained neurological symptoms.
-
healthAI Model COPE Revolutionizes Stroke Outcome Prediction Using Clinical Notes
New AI model COPE leverages unstructured clinical notes to significantly improve prediction of acute ischemic stroke recovery, outperforming traditional methods.